| SK3 (KCNN3) | |
|---|---|
| Protein Name | Small-conductance calcium-activated potassium channel 3 |
| Gene Symbol | KCNN3 |
| UniProt ID | Q9H5Y1 |
| Alternative Names | SK3, KCa2.3, Small conductance calcium-activated potassium channel 3 |
| Protein Family | KCNN family (SK channels) |
| Molecular Weight | 57 kDa (731 amino acids) |
| Subcellular Localization | Plasma membrane, Postsynaptic densities |
| Brain Expression | Hippocampus, cerebral [cortex](/brain-regions/cortex), substantia nigra, striatum |
SK3, encoded by the KCNN3 gene, is a small-conductance calcium-activated potassium (SK) channel that plays a critical role in regulating neuronal excitability and synaptic plasticity. SK channels are gated by intracellular calcium ions through binding to calmodulin, which serves as the calcium sensor[1]. SK3 is one of three neuronal SK channel isoforms (SK1/KCNN1, SK2/KCNN2, SK3/KCNN3) that contribute to the afterhyperpolarization (AHP) following action potentials, modulating firing frequency and neuronal adaptation.
SK3 channels are widely expressed in brain regions critical for learning, memory, and motor control, including the hippocampus, cerebral cortex, substantia nigra, and striatum. Dysregulation of SK3 channel function has been implicated in Alzheimer's disease, Parkinson's disease, epilepsy, and psychiatric disorders[2].
SK3 possesses a characteristic six-transmembrane domain architecture common to voltage-gated potassium channel superfamily members, with intracellular N- and C-termini:
| Domain/Feature | Details |
|---|---|
| Transmembrane segments | S1-S6, with S4 serving as voltage sensor |
| Pore loop | Between S5 and S6, contains selectivity filter (GGYG) |
| Calmodulin-binding domain | C-terminal tail, binds Ca²⁺-calmodulin for gating |
| N-terminal variable region | Contains targeting signals |
| C-terminal regulatory domain | Modulates channel trafficking and function |
Unlike voltage-gated channels, SK channels are primarily gated by intracellular calcium rather than membrane potential. Calmodulin serves as the calcium sensor: when calmodulin binds Ca²⁺, it undergoes a conformational change that opens the channel pore. This mechanism allows SK channels to translate changes in intracellular calcium into membrane hyperpolarization, providing negative feedback on neuronal excitability[3].
SK3 channels form homotetramers (four identical subunits) or can co-assemble with other SK isoforms to form heterotetrameric channels with distinct biophysical properties. The tetrameric assembly determines single-channel conductance and calcium sensitivity.
SK3 channels contribute to the medium afterhyperpolarization (mAHP) that follows action potential firing in neurons. This hyperpolarization:
SK3 channels modulate synaptic plasticity through their influence on neuronal firing patterns:
In the substantia nigra pars compacta and striatum, SK3 channels modulate dopaminergic neuron activity:
SK3 is expressed in astrocytes where it modulates:
SK3 channel dysfunction contributes to multiple aspects of AD pathogenesis:
Neuronal hyperexcitability: Reduced SK3 activity leads to increased neuronal excitability in cortical circuits, contributing to network dysfunction and seizures observed in early AD[4].
Synaptic dysfunction: SK3 channels are located at postsynaptic densities where they modulate synaptic plasticity. Aβ oligomers downregulate SK3 expression, impairing LTP and contributing to synaptic memory deficits.
Calcium dysregulation: SK3 is part of the calcium regulatory network. Impaired SK3 function disrupts calcium homeostasis, creating a vicious cycle with Aβ-induced calcium dysregulation.
Therapeutic implications: SK3 activators (e.g., EBIO, chlorzoxazone) improve synaptic plasticity and memory in AD models[5].
SK3 channels play a protective role in dopaminergic neurons:
Dopaminergic neuron vulnerability: SK3 expression is relatively low in substantia nigra pars compacta neurons, contributing to their inherent excitability and vulnerability to stressors.
Neuroprotection: Pharmacological activation of SK channels protects against MPTP-induced dopaminergic neuron loss in mouse models[6]. SK channel opening reduces excitotoxicity by limiting calcium influx through voltage-gated calcium channels.
Levodopa-induced dyskinesia: Altered SK3 expression in striatal medium spiny neurons contributes to dyskinesia development in PD patients treated with levodopa.
GBA and LRRK2 connections: Mutations in GBA and LRRK2 (PD risk genes) affect SK channel function through cellular stress pathways.
SK3 dysregulation is implicated in epilepsy:
SK3 is implicated in:
| Compound | Mechanism | Development Stage | Notes |
|---|---|---|---|
| EBIO | SK channel activator | Research tool compound | Increases SK channel open probability |
| Chlorzoxazone | SK channel activator | FDA-approved (muscle relaxant) | Shows promise in AD models |
| NS309 | SK channel activator | Research | Potent SK channel opener |
| Apo-SK1 | SK channel agonist | Preclinical | Peptide-based approach |
| Apamin | SK channel blocker | Research tool | Used to study SK function |
| Interacting Protein | Interaction Type | Functional Consequence |
|---|---|---|
| Calmodulin | Calcium sensor | Gating mechanism |
| KCNN2 (SK2) | Co-assembly | Heterotetramer formation |
| NMDA Receptor | Modulation | Calcium influx regulation |
| L-type Ca²⁺ Channel | Regulation | Calcium source for SK gating |
| PSD-95 | Anchoring | Synaptic localization |
Stocker M. KCa channels (SK/IK): a new therapeutic target?. Nature Reviews Neuroscience. 2004. ↩︎
Cheng Y, et al. SK channels and neurodegenerative diseases. Neurobiology of Aging. 2011. ↩︎
Faber ES, Sah P. Functions of SK channels in central neurons. Advances in Experimental Medicine and Biology. 2008. ↩︎
Georgiev D, et al. Altered SK channel function in an Alzheimer's disease mouse model. Neuropharmacology. 2018. ↩︎
Sahoo N, et al. SK channel modulation improves synaptic plasticity and memory deficits. Cell Reports. 2021. ↩︎
Tu P, et al. Blockade of SK channels protects against dopaminergic neuron loss in a mouse model of Parkinson's disease. Neurobiology of Disease. 2010. ↩︎
Shah MM, et al. SK channels and epilepsy. Epilepsy Research. 2000. ↩︎